News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

South Korea's Celltrion, Inc. (068270.KQ) In Talks For Stake Sale


1/2/2014 10:00:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

South Korea's Celltrion Inc said in a regulatory filing on Thursday that its largest shareholder is in talks with an interested party or parties to sell a controlling stake in the biotech firm. Celltrion received European backing to sell a copycat version of the blockbuster rheumatoid arthritis drug Remicade last year. Celltrion chose JP Morgan to advise on the sale last year, after its president said he will seek a buyer among multinational drugmakers for the controlling interest in the firm.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES